ILC Therapeutics, a Glasgow-based biotechnology company, has announced its latest pre-IPO funding round to advance its lead novel hybrid interferon drug candidate. The firm has also announced the appointment of Peter Bains as non-executive chairman, Richard Morgan as a non-executive director and All
Ilc Therapeutics
1-3 of 3 Articles
Medical Incubator Japan (MIJ), an independent venture capital fund investing in early-stage life sciences companies, is planning further UK healthcare investments in 2021 after completing two landmark UK investments in 2020. MIJ’s first investment was in Lanarkshire-based ILC Therapeutics, whi
Lanarkshire-based biotechnology company ILC Therapeutics (ILCT) has announced that it has secured significant investment from its first global investor Medical Incubator Japan (MIJ). The Scottish life sciences company, which has received international attention through its work exploring COVID-19 th